M3, Inc. (MTHRF)
OTCMKTS
· Delayed Price · Currency is USD
12.95
0.00 (0.00%)
May 27, 2025, 4:00 PM EDT
M3, Inc. Revenue
In the fiscal year ending March 31, 2025, M3, Inc. had annual revenue of 284.90B JPY with 19.26% growth. M3, Inc. had revenue of 79.38B in the quarter ending March 31, 2025, with 32.98% growth.
Revenue
284.90B JPY
Revenue Growth
+19.26%
P/S Ratio
4.92
Revenue / Employee
23.55M JPY
Employees
12,100
Market Cap
9.35B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 284.90B | 46.02B | 19.26% |
Mar 31, 2024 | 238.88B | 8.07B | 3.49% |
Mar 31, 2023 | 230.82B | 22.66B | 10.89% |
Mar 31, 2022 | 208.16B | 38.96B | 23.03% |
Mar 31, 2021 | 169.20B | 38.23B | 29.19% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |